Clinical Diagnostics Technology & Disease Research News | 360Dx
Guardant Health Raises Full-Year Guidance as Q3 Revenues Jump 34 Percent. Castle Biosciences Q3 Revenues up 39 Percent. CareDx Raises Full-Year Guidance as Q3 Revenues Grow 23 Percent. FDA Clears Qiagen QiaStat-Dx Meningitis/Encephalitis Panel. Top Five Articles on 360Dx Last Week: Qiagen Respiratory Test Cleared; Eurofins Acquisition; More.
Tempus to Offer Cancer Tests Through Flatiron's EMR | 360Dx
1 day ago · NEW YORK – AI diagnostics firm Tempus said on Tuesday that it has inked a deal with Roche's Flatiron Health that will allow healthcare providers to order Tempus' genomic cancer tests through Flatiron's electronic medical record system. Chicago-based Tempus said that the deal will provide access to its testing menu for about 4,200 healthcare ...
Qiagen, Danaher, Thermo Fisher Scientific, Others Gain 510(k ...
6 days ago · NEW YORK – The US Food and Drug Administration in October granted 510 (k) marketing clearances to molecular tests for infectious diseases, antimicrobial susceptibility tests, and a test for coagulation disorders, among others. Qiagen got the agency's go-ahead for a pair of syndromic panels that are used to identify the causes of respiratory ...
Exagen Q3 Revenues Decline 7 Percent | 360Dx
2 days ago · Exagen Q3 Revenues Decline 7 Percent. NEW YORK – Autoimmune testing firm Exagen on Tuesday announced its Q3 revenues declined 7 percent year over year. For the three months ended Sept. 30, the firm posted revenues of $12.5 million, down from $13.4 million in Q3 2023 and missing the consensus Wall Street estimates of $13.6 million. The firm ...
Top Five Articles on 360Dx Last Week: Tempus Buy of Ambry …
3 days ago · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) Tempus Expects $600M Ambry Genetics Acquisition to Accelerate Path to Cash Flow Breakeven 2) Survey: Users of Blood-Based MRD Testing for Solid Tumors Split on Approaches, Applications 3) After 'Flattening' Organizational Structure, QuidelOrtho Reinstates Full-Year Guidance
About Us - 360Dx
About Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Caris Life Sciences CDx Assay Nabs FDA Approval | 360Dx
Nov 6, 2024 · NEW YORK – Caris Life Sciences announced Wednesday that its MI Cancer Seek next-generation sequencing-based assay has received approval from the US Food and Drug Administration as a companion diagnostic for multiple therapies. The test uses total nucleic acid isolated from formalin-fixed paraffin-embedded tumor tissue specimens to detect ...
Diagnostic Technologies and Applications - 360Dx
The certification is for products used in hematology instruments manufactured globally, including instruments from Abbott, Beckman Coulter, and Siemens Healthineers. In the wake of suspending guidance to review the business in the first quarter of the year, QuidelOrtho has restructured and resumed offering a financial outlook.
Diagnostics Business & Financial News - 360Dx
Nov 5, 2024 · 360Dx Top 30 Falls 3 Percent in October. Breaking news on diagnostics business, policy, and funding. Real-time updates on clinical labs and the in vitro diagnostics market from 360Dx.
COVID-19 Diagnostics News - 360Dx
Iliinois Lab CEO Indicted on Multiple Counts of Fraud for COVID-19 Testing Scheme. Jun 14, 2024. Test Developers Using Cellulose, Gelatin, Chewing Gum to Make Sustainable Lateral Flow Assays. Jun 14, 2024.